Universal cervical length screening: implementation and outcomes

• Published in: American journal of obstetrics and gynecology Vol. 214; no. 4; pp. 523.e1 - 523.e8
• Main Authors: Temming, Lorene A., Durst, Jennifer K., Tuuli, Methodius G., Stout, Molly J., Dicke, Jeffrey M., Macones, George A., Cahill, Alison G.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.04.2016
• Subjects: Black or African American; Black People; Cervical Length Measurement; cervical length screening; Cervix Uteri - diagnostic imaging; Cohort Studies; Female; Humans; Mass Screening; Maternal Age; Missouri - epidemiology; Obesity - epidemiology; Obstetrics and Gynecology; Parity; Patient Acceptance of Health Care - statistics & numerical data; Pregnancy; Premature Birth - epidemiology; Premature Birth - prevention & control; preterm birth; preterm birth prevention; Retrospective Studies; Smoking - epidemiology; vaginal progesterone; Missouri; preterm birth; cervical length measurement; vaginal progesterone; preterm birth prevention; cervical length screening
• DOI: 10.1016/j.ajog.2016.02.002
• ISSN: 0002-9378; 1097-6868

Transvaginal measurement of cervical length (CL) has been advocated as a screening tool to prevent preterm birth, but controversy remains regarding the overall utility of universal screening. We aimed to evaluate the acceptability of a universal CL screening program. Additionally we evaluated risk factors associated with declining screening and subsequent delivery outcomes of women who accepted or declined screening. This was a retrospective cohort study of transvaginal CL screening at a single institution from July 1, 2011, through December 31, 2014. Institutional protocol recommended transvaginal CL measurement at the time of anatomic survey between 17-23 weeks in all women with singleton, viable pregnancies, without current or planned cerclage, with patients able to opt out. Patients with CL ≤20 mm were considered to have clinically significant cervical shortening and were offered treatment. We assessed acceptance rate, risk factors for declining CL screening, and the trend of acceptance of CL screening over time. We also calculated the prevalence of CL ≤25, ≤20, and ≤15 mm, and estimated the association between CL screening and spontaneous preterm birth. Of 12,740 women undergoing anatomic survey during the study period, 10,871 (85.3%; 95% confidence interval [CI], 84.7–85.9%) underwent CL screening. Of those, 215 (2.0%) had a CL ≤25 mm and 131 (1.2%) had a CL ≤20 mm. After the first 6 months of implementation, there was no change in rates of acceptance of CL screening over time (P for trend = .15). Women were more likely to decline CL screening if they were African American (adjusted odds ratio [aOR], 2.17; 95% CI, 1.93–2.44), obese (aOR, 1.18; 95% CI, 1.06–1.31), multiparous (aOR, 1.45; 95% CI, 1.29–1.64), age <35 years (aOR, 1.24; 95% CI, 1.08–1.43), or smokers (aOR, 1.42; 95% CI, 1.20–1.68). Rates of spontaneous preterm birth <28 weeks were higher in those who declined CL screening (aOR, 2.01; 95% CI, 1.33–3.02). Universal CL screening was implemented successfully with 85% of women screened. Overall incidence of short cervix was low and women with significant risk factors for preterm birth were more likely to decline screening. Patients who declined CL screening were more likely to be African American, obese, multiparous, age <35 years, and smokers. Rates of early, but not late, spontaneous preterm birth were significantly higher among women who did not undergo CL screening.